Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-13 Purchase |
2023-11-15 6:55 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
35,010 | $11.77 | $412,140 | 4,144,827 (Indirect Direct) |
View |
| 2023-11-13 Purchase |
2023-11-15 6:54 pm |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner |
35,010 | $11.77 | $412,140 | 4,131,207 (Indirect) |
View |
| 2023-11-08 Purchase |
2023-11-13 7:01 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
140,605 | $10.98 | $1,543,563 | 4,109,817 (Indirect Direct) |
View |
| 2023-11-08 Purchase |
2023-11-13 7:00 pm |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner |
140,605 | $10.98 | $1,543,563 | 4,096,197 (Indirect) |
View |
| 2023-11-03 Purchase |
2023-11-07 7:00 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
95,694 | $11.49 | $1,099,945 | 3,969,212 (Indirect Direct) |
View |
| 2023-11-03 Purchase |
2023-11-07 6:59 pm |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner |
95,694 | $11.49 | $1,099,945 | 3,955,592 (Indirect) |
View |
| 2023-09-28 Purchase |
2023-09-29 6:55 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
76,511 | $13.68 | $1,046,848 | 3,873,518 (Indirect Direct) |
View |
| 2023-09-28 Purchase |
2023-09-29 6:53 pm |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner |
76,511 | $13.68 | $1,046,848 | 3,859,898 (Indirect) |
View |
| 2023-09-26 Purchase |
2023-09-27 8:19 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
58,504 | $11.97 | $700,464 | 3,797,007 (Indirect Direct) |
View |
| 2023-09-26 Purchase |
2023-09-27 8:18 pm |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner |
58,504 | $11.97 | $700,464 | 3,783,387 (Indirect) |
View |
| 2023-09-22 Purchase |
2023-09-25 9:38 pm |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner |
100,740 | $11.19 | $1,127,064 | 3,724,883 (Indirect) |
View |
| 2023-09-22 Purchase |
2023-09-25 9:37 pm |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
100,740 | $11.19 | $1,127,064 | 3,738,503 (Indirect Direct) |
View |
| 2023-09-19 Purchase |
2023-09-20 06:23 am |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
1,500,000 | $17 | $25,500,000 | 3,637,763 (Indirect Direct) |
View |
| 2023-09-19 Purchase |
2023-09-20 06:16 am |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner |
1,500,000 | $17 | $25,500,000 | 3,624,143 (Indirect) |
View |
| 2023-09-19 Purchase |
2023-09-20 06:15 am |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Partners X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners VII LLC ARCH Venture Partners VII L.P. ARCH Venture Fund VII L.P. ARCH Venture Partners VIII LLC ARCH Venture Fund VIII Overage L.P. 10% Owner |
1,500,000 | $17 | $25,500,000 | 3,624,143 (Indirect) |
View |
| 2023-09-19 Purchase |
2023-09-19 9:47 pm |
Neumora Therapeutics Inc. | NMRA | Gosebruch Henry O President & CEO |
15,000 | $12.62 | $189,371 | 524,793 (Indirect Direct) |
View |
| 2023-09-19 Purchase |
2023-09-19 7:52 pm |
Neumora Therapeutics Inc. | NMRA | AMGEN INC 10% Owner |
1,764,705 | $17 | $29,999,985 | 35,368,653 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-08 Other |
2023-12-12 7:52 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
1,893,651 | $0 | 34,275,819 (Indirect) |
View |
| 2023-12-11 Option Award |
2023-12-12 6:16 pm |
N/A 2033-12-10 |
Neumora Therapeutics Inc. | NMRA | Duncan Jason Chief Legal Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2023-09-19 Conversion |
2023-09-21 08:30 am |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | FMR LLC See Remark 1 |
3,712,624 | $0 | 2,000,018 (Indirect) |
View |
| 2023-09-19 Conversion |
2023-09-20 06:23 am |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
17,438,324 | $0 | 3,637,763 (Direct) |
View |
| 2023-09-19 Conversion |
2023-09-20 06:16 am |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner |
17,424,704 | $0 | 3,624,143 (Indirect) |
View |
| 2023-09-19 Conversion |
2023-09-20 06:15 am |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Partners X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners VII LLC ARCH Venture Partners VII L.P. ARCH Venture Fund VII L.P. ARCH Venture Partners VIII LLC ARCH Venture Fund VIII Overage L.P. 10% Owner |
17,424,704 | $0 | 3,624,143 (Indirect) |
View |
| 2023-09-19 Conversion |
2023-09-19 7:52 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | AMGEN INC 10% Owner |
67,207,896 | $0 | 35,368,653 (Direct) |
View |
| 2023-09-14 Option Award |
2023-09-18 5:58 pm |
N/A 2033-09-13 |
Neumora Therapeutics Inc. | NMRA | Lenz Robert A. Head of R&D |
855,875 | $0 | 855,875 (Direct) |
View |
| 2023-09-14 Option Award |
2023-09-18 5:56 pm |
N/A 2033-09-13 |
Neumora Therapeutics Inc. | NMRA | Piacquad David Director |
46,455 | $0 | 46,455 (Direct) |
View |
| 2023-09-14 Option Award |
2023-09-18 5:54 pm |
N/A 2033-09-13 |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director |
46,455 | $0 | 46,455 (Direct) |
View |
| 2023-09-14 Option Award |
2023-09-18 5:52 pm |
N/A 2033-09-13 |
Neumora Therapeutics Inc. | NMRA | Halawa Alaa Director |
46,455 | $0 | 46,455 (Direct) |
View |
| 2023-09-14 Option Award |
2023-09-18 5:51 pm |
N/A 2033-09-13 |
Neumora Therapeutics Inc. | NMRA | Fust Matthew K Director |
27,802 | $0 | 27,802 (Direct) |
View |
| 2023-09-14 Option Award |
2023-09-18 5:50 pm |
N/A 2033-09-13 |
Neumora Therapeutics Inc. | NMRA | Ho Maykin Director |
27,802 | $0 | 27,802 (Direct) |
View |
Ownership |
2023-09-18 3:11 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Milligan Michael Lee See Remarks |
0 | $0 | 156,122 (Direct) |
View |
Ownership |
2023-09-14 9:29 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner |
0 | $0 | 28,045,420 (Indirect) |
View |
Ownership |
2023-09-14 9:22 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Fund X L.P. ARCH Venture Partners X L.P. ARCH Venture Fund X Overage L.P. ARCH Venture Partners X Overage L.P. ARCH Venture Partners VII LLC ARCH Venture Partners VII L.P. ARCH Venture Fund VII L.P. ARCH Venture Partners VIII LLC ARCH Venture Fund VIII Overage L.P. 10% Owner |
0 | $0 | 28,045,420 (Indirect) |
View |
Ownership |
2023-09-14 8:56 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Burow Kristina Director 10% Owner |
0 | $0 | 28,059,040 (Indirect) |
View |
Ownership |
2023-09-14 7:07 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Aurora Daljit Singh Chief Strategy Officer |
0 | $0 | 739,200 (Direct) |
View |
Ownership |
2023-09-14 7:05 pm |
N/A 2031-04-22 |
Neumora Therapeutics Inc. | NMRA | Ho Maykin Director |
0 | $0 | 95,586 (Direct) |
View |
Ownership |
2023-09-14 7:04 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | Suh Carol Y. Chief Operating Officer |
0 | $0 | 783,800 (Direct) |
View |
Ownership |
2023-09-14 7:01 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | FMR LLC See Remark 1 10% Owner |
0 | $0 | 5,624,353 (Indirect) |
View |
Ownership |
2023-09-14 6:59 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | BERNS PAUL L Director |
0 | $0 | 9,188,536 (Direct) |
View |
Ownership |
2023-09-14 6:58 pm |
N/A N/A |
Neumora Therapeutics Inc. | NMRA | AMGEN INC 10% Owner |
0 | $0 | 33,603,948 (Direct) |
View |